Immupharma is headquartered in London, GB
Immupharma Office Locations
Immupharma has offices in London, Mulhouse and Sarnen
London, GB (HQ)
50 Broadway
Sarnen, CH
10 Poststrasse
Mulhouse, FR
5 Rue Du Rhône
Immupharma Data and Metrics
Immupharma Financial Metrics
Immupharma's revenue was reported to be £76.4 k in FY, 2015 which is a 59% decrease from the previous period.
GBP
Revenue (FY, 2015) | 76.4 k |
Revenue growth (FY, 2014 - FY, 2015), % | (59%) |
Net income (FY, 2015) | (3.9 m) |
Market capitalization (23-Jun-2017) | 69.4 m |
Closing share price (23-Jun-2017) | 0.5 |
Cash (31-Dec-2015) | 833.4 k |
Immupharma's current market capitalization is £69.4 m.
| GBP | FY, 2013 | FY, 2014 | FY, 2015 |
|---|---|---|---|
Revenue | 184.8 k | 76.4 k | |
Revenue growth, % | (59%) | ||
Pre tax profit | (4.4 m) | (3.3 m) | (4.5 m) |
Net Income | (3.7 m) | (2.9 m) | (3.9 m) |
| GBP | FY, 2013 | FY, 2014 | FY, 2015 |
|---|---|---|---|
Cash | 5.4 m | 5.4 m | 833.4 k |
Current Assets | 6.5 m | 6.1 m | 2.4 m |
PP&E | 97.1 k | 366.4 k | 280.1 k |
Goodwill | 602.1 k | 560.5 k | 522.5 k |
Total Assets | 7.2 m | 7.1 m | 3.2 m |
Accounts Payable | 433.8 k | 386.6 k | 637.9 k |
Current Liabilities | 1 m | 991 k | 1.2 m |
Retained Earnings | (3.7 m) | (2.9 m) | (3.9 m) |
Total Equity | 5.4 m | 5.7 m | 1.7 m |
Financial Leverage | 1.3 x | 1.2 x | 1.9 x |
| GBP | FY, 2013 | FY, 2014 | FY, 2015 |
|---|---|---|---|
Cash From Operating Activities | (3.9 m) | (2.5 m) | (4.1 m) |
Cash From Financing Activities | 191.5 k | 3 m | (310.1 k) |
Income Taxes Paid | 744.5 k | 468.7 k | 651 k |
| GBP | Y, 2015 |
|---|---|
Revenue/Employee | 7.6 k |
Financial Leverage | 1.9 x |
